Lucy Tecle

Ms. Lucy Tecle


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2025 in Cancers
Verified
Journal Article
Open access
PDF file
SHSamrin F. Habbani
Samrin F. Habbani
Sayeh DowlatshahiSayeh Dowlatshahi
Sayeh Dowlatshahi
NLNathanael Lichti
Nathanael Lichti
MBMeaghan Broman
Meaghan Broman
LTLucy Tecle
Lucy Tecle
Sulma I. MohammedSulma I. Mohammed
Sulma I. Mohammed
Background/Objectives: Cervical cancer (CC) is a significant global health challenge, particularly in low- and middle-income countries (LMICs), where limited access to human papillomavirus (HPV) vaccination and effective CC screening results in a majority of cases and fatalities among women. Moreover, existing vaccines do not target HPV-independent cancers. Current screening methods are expensive and time-consuming, with a limited emphasis on CC protein biomarkers. Therefore, we aimed to validate critical markers that allow the development of affordable point-of-care screening tests for resource-limited settings. Methods: This study first optimized a cell lysis and protein extraction protocol for CC cell lines and clinical cervical swabs. Subsequently, four proteins—topoisomerase II alpha (TOP2A), minichromosome maintenance complex component 2 (MCM2), valosin-containing protein (VCP), and cyclin-dependent kinase inhibitor 2A (p16INK4a)—were quantified in the resulting lysates using enzyme-linked immunosorbent assays, as well as in cervical tumors and squamous intraepithelial lesions (SILs) using immunohistochemistry for further validation. Results: Acetone precipitation allowed for efficient cell isolation, and radioimmunoprecipitation assay buffer yielded the highest protein recovery. VCP and p16INK4a were overexpressed across all cancer cell lines compared to primary cells. All four biomarkers were overexpressed in high-grade SIL (HSIL) swab specimens and tumor samples, including CC subtypes, G1–G3 tumor grades, and HSILs. Lastly, we showed that the proteins could accurately classify swabs and tissue specimens into clinically relevant groups. Conclusions: The quantitative analysis of these biomarkers, along with the subsequent sensitive and specific clinical classification, highlights their potential application in SIL early detection and CC prevention, particularly in LMICs.

30 December 2025 in HardwareX
Verified
Journal Article
Open access
LTLucy Tecle
Lucy Tecle
SRShannon Riegle
Shannon Riegle
APAndrew Piepho
Andrew Piepho
JLJacqueline Linnes
Jacqueline Linnes
Paper-based diagnostics are promising for point-of-care testing, but their assembly is often manual and can introduce alignment variability. To address this, we developed a low-cost, open-source workstation that repurposes a three-axis computer numerical control (CNC) machine for automated pick-and-place assembly of paper-based assays. The system integrates an Arduino-based controller with GRBL firmware, a custom vacuum end effector, and component holders to handle delicate assay components. This design eliminates reliance on proprietary CNC controls, reducing the costs to under $900 while enabling machine-agnostic adaptability. Performance was validated across dipstick, lateral flow immunoassay, and custom duplex immunoassay formats. Linear placement accuracy averaged ∼0.5–0.6 mm (within functional tolerance for diagnostic readability), while angular deviations (1–3°) remained acceptable for sample flow. Control line intensity in CNC-assembled assays were statistically indistinguishable from hand-assembled assays, confirming preserved diagnostic performance. By lowering the barrier to automated fabrication, this workstation provides an accessible platform for academic labs, startups, and decentralized environments to prototype and scale paper-based diagnostics. The open-source hardware and design files expand opportunities for reproducible, affordable diagnostic assembly in early-stage research and development.